A new study reveals how Artemisia annua unique molecule artemisinin and its derivatives are able not only to treat parasitic disorders but also to balance the immune system that directly benefits the host.
Details
The newspaper interviews our CEO of Biotech Tricopharming Research Luis Matias, who explains how our Artennua product works and what growth and development prospects we expect. Luis also focuses on the strategic importance of Canary Islands for Artennua production. Indeed, Artennua could become an important crop for the region given its valuable and international trade…
Details
We are delighted to share with you our new flyer showing Artennua potential on Animal Health.Plants are very important for animal health. As within the human population, incidence of chronic disorders are growing in both companion pets and livestock…
Details
Biotech Tricopharming Research wins its first Fyde CajaCanarias Emprendedores 2019 award.
Today, on World Entrepreneur Day, we received an amazing news: we are winners of the 23th Canary Islands Entrepreneurship Award by FYDE. The CajaCanaria Bank Foundation supporting the entrepreneurship (Fundación Canaria para la Formación y Desarrollo Empresarial de CajaCanarias) selected the finalists from different islands. The jury was composed by the General Director of the…
Details
Tricopharming as been selected as finalist company in the Canary Islands Entrepreneurship Award by Fyde CajaCanarias. Tomorrow our CEO Luis Matías Hernández will give its pitch about Artennua, first Tricopharming product. Artennua is produced in our ecologic farm El Pico in Tejina, Tenerife Island. The project started in Tenerife in 2017 thanks to CDTI funding and…
Details
Program SER Castilla-La Mancha A scientist from Cuenca, a medicinal plant and a treatment against malaria.
DetailsInnovation and agriculture, medicinal plants and biotechnology, this is Tricopharming. Using biological techniques we stimulate the natural capacity of the plants trichomes to be molecules factory. A well done article titled “Biopharmaceutical Agriculture, from the laboratory to the field”, Newspaper La Vanguardia tells our story: our company, our first product and our plans for the…
Details
Pharmaceutical agriculture, from the laboratory to the field
Sequentia Biotech creates the spin-out Biotech Tricopharming Research to market Artennua, its first biopharmaceutical agriculture product.